Concepedia

Ruba Al‐Abdulla

RA

Statistics

Publications

11

Citations

302

H-Index

10

Active since

2017

Affiliations

Instituto de Investigación Biomédica de Salamanca(Current)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Universidad de Salamanca

Instituto de Salud Carlos III

Biogipuzkoa Health Research Institute

Ruba Al‐Abdulla is an author at Instituto de Investigación Biomédica de Salamanca specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2017–2023

11

Publications

11

Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy

Elisa Lozano, Rocı́o I.R. Macı́as, María J. Monte et al. · Hepatology · 2019 · 54 citations · Full text

, , +17

The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma

Andreas Geier, Rocı́o I.R. Macı́as, Dominik Bettinger et al. · Oncotarget · 2017 · 49 citations · Full text

, , +17

Epigenetic events involved in organic cation transporter 1‐dependent impaired response of hepatocellular carcinoma to sorafenib

Ruba Al‐Abdulla, Elisa Lozano, Rocı́o I.R. Macı́as et al. · British Journal of Pharmacology · 2018 · 48 citations · Full text

, , +17

Screening of Relevant Metabolism-Disrupting Chemicals on Pancreatic β-Cells: Evaluation of Murine and Human In Vitro Models

Ruba Al‐Abdulla, Hilda Ferrero, Sergi Soriano et al. · International Journal of Molecular Sciences · 2022 · 34 citations · Full text

, , +15

Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma

Monika Lewińska, Ekaterina Zhuravleva, Letizia Satriano et al. · Gastroenterology · 2023 · 32 citations · Full text

, , +17

1–5 of 11